Back to Search Start Over

[Radiotherapy of bladder cancer]

Authors :
P. Martin
Jean-Léon Lagrange
Llacer Moscardo C
D. Azria
Norbert Ailleres
Bruno Chauvet
Pascal Fenoglietto
O. Riou
M. Charissoux
O. Lauche
Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM)
CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
Département de radiothérapie
CRLCC Val d'Aurelle - Paul Lamarque
Institut Sainte Catherine [Avignon]
Service de radiothérapie [Mondor]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
Source :
Cancer/Radiothérapie, Cancer/Radiothérapie, Elsevier Masson, 2016, 20, pp.S196-S199. ⟨10.1016/j.canrad.2016.07.010⟩, Cancer Radiothérapie, Cancer Radiothérapie, Elsevier Masson, 2016, 20, pp.S196-S199. ⟨10.1016/j.canrad.2016.07.010⟩
Publication Year :
2016
Publisher :
HAL CCSD, 2016.

Abstract

International audience; Surgery (radical cystectomy) is the standard treatment of muscle-invasive bladder cancer. Radiochemotherapy has risen as an alternative treatment option to surgery as part as organ-sparing combined modality treatment or for patients unfit for surgery. Radiochemotherapy achieves 5-year bladder intact survival of 40 to 65% and 5-year overall survival of 40 to 50% with excellent quality of life. This article introduces the French recommendations for radiotherapy of bladder cancer: indications, exams, technique, dosimetry, delivery and image guidance.

Details

Language :
French
ISSN :
12783218 and 17696658
Database :
OpenAIRE
Journal :
Cancer/Radiothérapie, Cancer/Radiothérapie, Elsevier Masson, 2016, 20, pp.S196-S199. ⟨10.1016/j.canrad.2016.07.010⟩, Cancer Radiothérapie, Cancer Radiothérapie, Elsevier Masson, 2016, 20, pp.S196-S199. ⟨10.1016/j.canrad.2016.07.010⟩
Accession number :
edsair.doi.dedup.....805dd56c71e1974527e59f95ed30d11c
Full Text :
https://doi.org/10.1016/j.canrad.2016.07.010⟩